You are here: Industry Insights > Market News

Market News

Professor James Rothman, Nobel Laureate, to Join the Board of Noscendo GmbH Biotech Newswire
August 21, 2024
Noscendo GmbH announced that Professor James Rothman has agreed to serve on its board as an independent director.
Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® Demonstrates Positive Cardiovascular Safety in a Large, Real-World Evidence Study Biotech Newswire
August 28, 2024
Currax Pharmaceuticals LLC announced the results of a Cardiovascular Health Outcomes Analysis.The results showed there is no evidence of excess cardiovascular risk.
Avantor Triumphs with Three Awards at Korea Biopharma Excellence Awards 2024 PharmaSources
August 26, 2024
Avantor, Inc. has secured three prestigious awards at the esteemed Korea Biopharma Excellence Awards (KBEA) 2024.
Touchlight to Supply GMP dbDNA to Support University of Nottingham’s Clinical Study for a Next-Generation Vaccine for Zika Virus Biotech Newswire
August 22, 2024
Touchlight announced the clinical supply of its proprietary dbDNA™ to the University of Nottingham for research and development of a next-generation DNA vaccine targeting the Zika virus.
InnoCare Releases 2024 Interim Results and Business Highlights August 21, 2024
InnoCare Pharma announced the 2024 interim results and corporate update as of 30 June 2024.
osteolabs Publishes First Real-World Evidence Data from Close to 3, 000 OsteoTest Patient Samples Biotech Newswire
August 16, 2024
osteolabs GmbH announced the publication of real-world evidence data from close to 3,000 OsteoTest patient samples in the prestigious journal Bone.
NEW OPTURA®PALM® Handheld Contactless Biomass Sensor from Aber Offers Accurate Cell Density Measurement in Seconds Without Sampling Biotech Newswire
August 09, 2024
Aber Instruments (Aber) is delighted to introduce its new OPTURA® PALM® handheld biomass sensor.
Freudenberg Expands Biopharma Product Portfolio with Single-use Assemblies Biotech Newswire
August 01, 2024
Freudenberg Medical has expanded its biopharma product portfolio to custom single-use assemblies.
iotaSciences Raises Equity Financing Round to Drive Further Business Expansion for Its Automated Single-Cell Biology Handling Technologies Biotech Newswire
August 01, 2024
New funds will support ongoing commercial activities in Europe, the U.S and Asia and further enhance the development of a next-generation single-cell cloning platform.
British Journal of Cancer: Zurletrectinib Is a Next-Generation TRK Inhibitor With Strong Intracranial Activity Against NTRK Fusion-Positive Tumors With On-Target Resistance to First-generation Agents July 31, 2024
Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumors with on-target resistance to first-generation agents.